QUANTITY | PRIC PER g | SAVE AMOUNT |
---|---|---|
1 to 1 | EUR 55.00 /g | 0% |
2 to 2 | EUR 46.75 /g | 15% |
3 to 4 | EUR 35.75 /g | 35% |
5 to 9 | EUR 30.25 /g | 45% |
10 to 24 | EUR 24.75 /g | 55% |
25 to 49 | EUR 22.00 /g | 60% |
50 to 99 | EUR 19.25 /g | 65% |
100 + | EUR 16.50 /g | 70% |
POPULAR PRODUCT
Many customers bought this product recently.
αMT, or α-Methyltryptamine, is a synthetic indole alkaloid that belongs to the tryptamine class. This compound was initially developed by Upjohn in the 1960s and was briefly utilized in the Soviet Union as an antidepressant under the trade name Indopan.
Indopan was prescribed in doses ranging from 5 to 10 mg, which is considerably lower than the amounts typically used for recreational purposes. This historical usage highlights the compound's potential therapeutic applications, despite its more common association with recreational use today.
αMT features a core structure that is characteristic of tryptamines, consisting of a bicyclic indole heterocycle. This structure is attached at the R3 position to an amino group via an ethyl side chain. Notably, αMT is distinguished by a methyl group substitution at the alpha carbon (Rα) of its tryptamine backbone.
In its freebase form, αMT exists as a racemate, containing both its (R-) and (S-) enantiomers. This racemic nature can influence its pharmacological effects and interactions within the body.
αMT functions as a balanced reuptake inhibitor and releasing agent for three primary monoamines: serotonin, norepinephrine, and dopamine. Additionally, it acts as a non-selective serotonin receptor agonist, which contributes to its psychoactive properties.
The psychedelic effects of αMT are primarily attributed to its role as a partial agonist at the 5-HT2A receptor. This interaction is crucial for the compound's ability to induce altered states of consciousness and other psychedelic experiences.
Beyond its psychedelic effects, αMT also serves as a releasing agent for serotonin, noradrenaline, and dopamine. Furthermore, it exhibits very weak, non-selective reversible inhibition of monoamine oxidase (RIMA) both in vitro and in vivo. However, this RIMA activity is unlikely to be significant at typical dosages.
AMT Succinate Powder is for research use only and not intended for human consumption!
AMT Succinate Powder stock last updated at: April 2025